Trial Profile
Phase 2, randomised trial to demonstrate the efficacy of linezolid in Korean patients with chronic extensively drug-resistant (XDR) pulmonary tuberculosis.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2015
Price :
$35
*
At a glance
- Drugs Linezolid (Primary)
- Indications Pulmonary tuberculosis
- Focus Therapeutic Use
- 18 Aug 2015 New trial record